Today's decision by the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the reclassification of azithromycin for the treatment of chlamydia infection will mean convenient and effective care for patients, said the Royal Pharmaceutical Society of Great Britain (RPSGB). Azithromyc...

Today's decision by the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the reclassification of azithromycin for the treatment of chlamydia infection will mean convenient and effective care for patients, said the Royal Pharmaceutical Society of Great Britain (RPSGB). Azithromyc...

LONDON, July 3 /PRNewswire/ -- Responding to the NHS next stage review, Our vision for primary and community care, Howard Duff, Director for England at the Royal Pharmaceutical Society of Great Britain, said:

LONDON, June 25 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the digital 'front door' to the NHS releases a new, improved, guide aimed to help men aged 18-39 live healthier lifestyles.

LONDON, June 24 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the digital 'front door' to the NHS, launches a Live well guide on women's health aged 18-39 aimed at helping women find out more about maintaining a healthy lifestyle.

Pinnacle Biologics, une société privée offrant des solutions pharmaceutiques et biotechnologiques en service intégral, a annoncé aujourd'*** qu'elle avait conclu un accord avec Chiltern International, Inc. pour les activités de services de pharmacovigilance/rapports de sécurité et d'informations...

Relsys International, fournisseur leader de solutions de sécurité médicamenteuse, de pharmacovigilance et de gestion des risques pour le secteur pharmaceutique, a annoncé que M. Bruce Palsulich a rejoint la société en tant que directeur de l'innovation et de la stratégie, relevant directement du...

LONDON, June 20 /PRNewswire/ -- Unite, the UK's largest union, is today calling for the government to act quickly and decisively to safeguard the jobs and skills of up to 1000 people presently working on the GBP12.7bn NHS IT contract for the IT services company Fujitsu.

LONDON, June 18 /PRNewswire/ -- Responding to yesterday's announcement made by Alan Johnson, Secretary of State for Health, of a Government review in to the current policy on 'top-up' payments for NHS treatment, the Royal Pharmaceutical Society of Great Britain (RPSGB) has called for consistency...

- Strong Government Support Continues to Draw Top Research Institutes, Talent, and Corporate Labs That Are Looking to Place Strategic Bets for the Future